1974P A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder
Year: 2024
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: G.J. DeCastro, M. Stein, C. Abate-Shen, C. Miles, J. Gray, B. Joffe, C. Anderson, A. Lenis, J.M.M. McKiernan
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Sanofi
OpenAlex ID: W4402565781